AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec
· Financial Post
MONTREAL, April 30, 2026 (GLOBE NEWSWIRE) -- AbbVie (NYSE: ABBV), jointly with adMare BioInnovations, today recognized RIME Therapeutics as the recipient of the AbbVie Biotech Innovators Award, a prize designed to help foster innovation and support growth in Quebec’s life sciences sector. Read More
Visit syntagm.co.za for more information.